Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BEAMing sheds light on drug resistance.

Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Dec 2011

Lauring Josh, Park Ben Ho

Abstract excerpt

Targeted therapies against somatically altered genes are currently used for the treatment of many human cancers. The nascent technology known as BEAMing has the potential to increase the clinical utility of these agents because it allows for the detection of cancer mutations in peripheral blood,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to DNA Mutational Analysis
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 22065078
DOI: 10.1158/1078-0432.CCR-11-2556
PMCID: PMC3243814

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22065078-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

BEAMing sheds light on drug resistance.PMID 22065078Read ↗

Managing drug resistance in cancer: lessons from HIV therapySemantic proximity Read ↗

The genomics revolution and radiotherapy.Semantic proximity Read ↗

Drug resistance: origins, evolution and characterization of genomic clones and the tumor ecosystem to optimize precise individualized therapySemantic proximity Read ↗

Targeting DNA damage response pathways in tumor drug resistance: Mechanisms, clinical implications, and future directionsSemantic proximity Read ↗

Somatic alterations as the basis for resistance to targeted therapies.Semantic proximity Read ↗

Circumventing Cancer Drug Resistance in the Era of Personalized MedicineSemantic proximity Read ↗

Molecular Mechanisms of Cancer Drug Resistance: Emerging Biomarkers and Promising Targets to Overcome Tumor ProgressionSemantic proximity Read ↗

Advances in Precision Oncology: From Molecular Profiling to Regulatory-Approved Targeted TherapiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.